One day in early May, web-based prediction market platform Kalshi listed two contracts tied to Compass Pathways’ psilocybin ...

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Inovio Pharmaceuticals and Novavax stocks pare back earlier gains as the rally loses enthusiasm. Following a robust rally, Moderna appears to be regaining leadership within the biotech space. Inhibrx ...

Research Alliance III follows a few months after Cormorant Asset Management priced a $150 million IPO for its own blank-check ...

All these three companies will finalise their IPO share allotment by May 26, while trading in Q-Line Biotech, and Bio Medica Laboratories shares will commence on the NSE Emerge effective May 29.

On this week’s episode of “The Readout LOUD,” the hosts discuss STAT's Breakthrough Summit West, where powerful leaders from ...

Krystal Biotech, a Pittsburgh-based gene therapy company, has picked up a key win across the Atlantic, securing UK regulatory ...

Emerging out of stealth mode, biotech startup StrainX Bioworks has raised $13 Mn (around ₹124 Cr) in a funding round led by Prime Venture Partners and Leo Capital. The round also saw participation ...

For Wall Street, the political risk of investing in drug companies has been demoted in comparison to other concerns ...